1-methyl-3-[2-(3-methoxyphenyl)-2-oxoethyl]-1H-imidazolium bromide | 103793-22-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-methyl-3-[2-(3-methoxyphenyl)-2-oxoethyl]-1H-imidazolium bromide
• 英文别名: 1-methyl-3-[2-(3'-methoxyphenyl)-2-oxo-ethyl]imidazolium bromide；Proglycosyn；1-(3-methoxyphenyl)-2-(3-methylimidazol-3-ium-1-yl)ethanone;bromide
• CAS: 103793-22-2
• 化学式: Br*C₁₃H₁₅N₂O₂
• 分子量: 311.178
• InChiKey: LDFPYRMYXCBYSZ-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.79
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  35.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  N-甲基咪唑 生成 1-methyl-3-[2-(3-methoxyphenyl)-2-oxoethyl]-1H-imidazolium bromide
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• Method for treating fibrotic diseases or other indications IC
  申请人：Alteon, Inc.

  公开号：US20020068729A1

  公开（公告）日：2002-06-06

  Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I: 1

  提供了一种处理、改善或预防动物包括人类发明的指示的方法，包括给予公式I的化合物的有效量：1
• Method for treating fibrotic diseases or other indications with imidazolium agents
  申请人：Alteon, Inc.

  公开号：US20030176426A1

  公开（公告）日：2003-09-18

  Provided is a method of treating or ameliorating an indication of the invention in an animal, including a human, by administering an effective amount of a compound of the formula I: 1 wherein R 1 , R 2 , M, X and Z are as described supra. Also provided are certain imidazolium compounds and pharmaceutical compositions containing the imidazolium compounds.

  提供了一种治疗或改善动物（包括人类）发明的征兆的方法，通过给予公式I的有效量的化合物： 1 其中R 1 ，R 2 ，M，X和Z如上所述。还提供了一些咪唑啉化合物和包含咪唑啉化合物的药物组合物。
• Substituted imidazolium salts and their use for the inhibition of protein ageing.
  申请人：ALTEON Inc.

  公开号：EP1213282A1

  公开（公告）日：2002-06-12

  The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein ageing). Accordingly, compositions are disclosed which comprise substituted imidazolium compounds capable of inhibiting the formation of, as well as reversing already formed, advanced glycosylation end products of target proteins. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein ageing can be treated.

  本发明涉及用于抑制和逆转非酶交联（蛋白老化）的组合物和方法。因此，揭示了包括替代咪唑化合物的组合物，能够抑制目标蛋白质的高级糖基化终产物的形成，并逆转已经形成的高级糖基化终产物。该方法包括将目标蛋白质与该组合物接触。该发明可预见在工业和治疗应用中得到应用，因为可以治疗食物腐败和动物蛋白质老化。
• Substituted imidazoliums and methods of use therefor
  申请人：——

  公开号：US20040198795A1

  公开（公告）日：2004-10-07

  The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, compositions are disclosed which comprise substituted imidazolium compounds capable of inhibiting the formation of, as well as reversing already formed, advanced glycosylation endproducts of target proteins. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.

  本发明涉及用于抑制和逆转非酶交联（蛋白质老化）的组合物和方法。因此，揭示了包括取代咪唑化合物的组合物，其能够抑制目标蛋白质的高级糖基化终产物的形成，并逆转已经形成的高级糖基化终产物。该方法包括将目标蛋白质与该组合物接触。该发明可用于工业和治疗应用，因为可用于处理食品腐败和动物蛋白质老化。
• Method for treating fibrotic diseases or other indications ID
  申请人：——

  公开号：US20020177586A1

  公开（公告）日：2002-11-28

  Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I: 1

  提供了一种在动物中（包括人类）治疗、改善或预防本发明指示的方法，其中包括给予化合物I的有效量：1。